Eris Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences Limited has announced the results of its postal ballot conducted via remote e-voting. Shareholders approved the appointment of Mr. Vineet Varma (DIN: 11600100) as an Independent Director of the Company. The special resolution was passed with 99.92% votes in favour (1,22,49,848 votes) against just 0.08% (97,025 votes). A total of 299 members participated in the voting, representing 88.49% of the total paid-up capital. The e-voting period ran from April 24, 2026 to May 23, 2026, and the scrutinizer's report was submitted on May 25, 2026.
The appointment of Vineet Varma as an Independent Director strengthens the Board's independence and governance structure. The overwhelming shareholder approval signals strong confidence in the appointment and is marginally positive for the stock.